AI-enabled plaque assessments help cardiologists ID high-riskCAD patients
Cardiovascular BusinessFDA-approved AI software from Denver-based Cleerly was used to evaluate coronary CT angiography (CCTA) images of these patients and assess theirrisks …
Read the original at cardiovascularbusiness.com ↗
- Topics
- Healthcare
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”